Epic Pharma. LLC.
FDA Approved Drugs
Epic Pharma. LLC.
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 360
- Latest Approval Date May 13, 2026
- Data Source FDA
- First Approval Date Jan 01, 1982
Company Overview
Social Profiles
Company Snapshot
Epic Pharma. LLC.
227-15 N. Conduit Ave.Laurelton, NY 11413, USA
U.S.A
www.epic-pharma.com/ E.Korzik@Epic-Pharma.com View on MapFDA Approved Drug Records ( 360 records )
Drug Name
ACETAZOLAMIDE
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2024-05-14
Active Ingredient
ACETAZOLAMIDE
Application Number
218023
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2024-05-14
Regulatory Status
RX
Drug Name
ACETAZOLAMIDE
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2024-05-14
Active Ingredient
ACETAZOLAMIDE
Application Number
218023
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2024-05-14
Regulatory Status
RX
Drug Name
AK-PENTOLATE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1982-01-01
Active Ingredient
CYCLOPENTOLATE HYDROCHLORIDE
Application Number
85555
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
AKBETA
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
1996-10-29
Active Ingredient
LEVOBUNOLOL HYDROCHLORIDE
Application Number
74779
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
1996-10-29
Regulatory Status
Discontinued
Drug Name
AKBETA
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
1996-10-29
Active Ingredient
LEVOBUNOLOL HYDROCHLORIDE
Application Number
74780
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
1996-10-29
Regulatory Status
Discontinued
Drug Name
AKPRO
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
1995-09-29
Active Ingredient
DIPIVEFRIN HYDROCHLORIDE
Application Number
74382
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
1995-09-29
Regulatory Status
Discontinued
Drug Name
AKTOB
Product Number
1
Dosage Form
-
Strength
0.3%
Approval Date
1996-01-31
Active Ingredient
TOBRAMYCIN
Application Number
64096
Product Number
1
Dosage Form
-
Strength
0.3%
Approval Date
1996-01-31
Regulatory Status
Discontinued
Drug Name
ALBUTEROL SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 0.083% BASE
Approval Date
1999-02-09
Active Ingredient
ALBUTEROL SULFATE
Application Number
75063
Product Number
1
Dosage Form
-
Strength
EQ 0.083% BASE
Approval Date
1999-02-09
Regulatory Status
Discontinued
Drug Name
AMICAR
Product Number
2
Dosage Form
-
Strength
250MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
AMINOCAPROIC ACID
Application Number
15229
Product Number
2
Dosage Form
-
Strength
250MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
AMINOCAPROIC ACID
Product Number
1
Dosage Form
-
Strength
0.25GM/ML
Approval Date
1998-09-02
Active Ingredient
AMINOCAPROIC ACID
Application Number
74759
Product Number
1
Dosage Form
-
Strength
0.25GM/ML
Approval Date
1998-09-02
Regulatory Status
Discontinued
Drug Name
AMIODARONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2006-07-05
Active Ingredient
AMIODARONE HYDROCHLORIDE
Application Number
76232
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
2006-07-05
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2009-04-08
Active Ingredient
AMLODIPINE BESYLATE
Application Number
78552
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2009-04-08
Regulatory Status
RX
Drug Name
AMLODIPINE BESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2009-04-08
Active Ingredient
AMLODIPINE BESYLATE
Application Number
78552
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2009-04-08
Regulatory Status
RX
Drug Name
AMLODIPINE BESYLATE
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2009-04-08
Active Ingredient
AMLODIPINE BESYLATE
Application Number
78552
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2009-04-08
Regulatory Status
RX
Drug Name
AMPHETAMINE SULFATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2020-10-27
Active Ingredient
AMPHETAMINE SULFATE
Application Number
213980
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2020-10-27
Regulatory Status
RX
Drug Name
AMPHETAMINE SULFATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2020-10-27
Active Ingredient
AMPHETAMINE SULFATE
Application Number
213980
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2020-10-27
Regulatory Status
RX
Drug Name
AZELASTINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2016-11-08
Active Ingredient
AZELASTINE HYDROCHLORIDE
Application Number
203660
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2016-11-08
Regulatory Status
Discontinued
Drug Name
AZELASTINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY
Approval Date
2019-05-17
Active Ingredient
AZELASTINE HYDROCHLORIDE
Application Number
207610
Product Number
1
Dosage Form
-
Strength
0.137MG/SPRAY
Approval Date
2019-05-17
Regulatory Status
RX
Drug Name
AZITHROMYCIN
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/5ML
Approval Date
2018-04-09
Active Ingredient
AZITHROMYCIN
Application Number
207531
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE/5ML
Approval Date
2018-04-09
Regulatory Status
RX
Drug Name
AZITHROMYCIN
Product Number
2
Dosage Form
-
Strength
EQ 200MG BASE/5ML
Approval Date
2018-04-09
Active Ingredient
AZITHROMYCIN
Application Number
207531
Product Number
2
Dosage Form
-
Strength
EQ 200MG BASE/5ML
Approval Date
2018-04-09
Regulatory Status
RX
Drug Name
BALANCED SALT
Product Number
1
Dosage Form
-
Strength
0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6.4MG/ML;1.7MG/ML
Approval Date
2006-09-27
Active Ingredient
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
Application Number
75503
Product Number
1
Dosage Form
-
Strength
0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6.4MG/ML;1.7MG/ML
Approval Date
2006-09-27
Regulatory Status
Discontinued
Drug Name
BENZPHETAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2007-10-29
Active Ingredient
BENZPHETAMINE HYDROCHLORIDE
Application Number
40714
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2007-10-29
Regulatory Status
Discontinued
Drug Name
BENZPHETAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2015-12-15
Active Ingredient
BENZPHETAMINE HYDROCHLORIDE
Application Number
90346
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2015-12-15
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1989-02-27
Active Ingredient
BENZTROPINE MESYLATE
Application Number
72264
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1989-02-27
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
1989-02-27
Active Ingredient
BENZTROPINE MESYLATE
Application Number
72265
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
1989-02-27
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
1989-02-27
Active Ingredient
BENZTROPINE MESYLATE
Application Number
72266
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
1989-02-27
Regulatory Status
RX
Drug Name
BETAXOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1999-10-22
Active Ingredient
BETAXOLOL HYDROCHLORIDE
Application Number
75541
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1999-10-22
Regulatory Status
RX
Drug Name
BETAXOLOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
1999-10-22
Active Ingredient
BETAXOLOL HYDROCHLORIDE
Application Number
75541
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
1999-10-22
Regulatory Status
RX
Drug Name
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
2.5MG;6.25MG
Approval Date
2000-09-25
Active Ingredient
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Application Number
75579
Product Number
1
Dosage Form
-
Strength
2.5MG;6.25MG
Approval Date
2000-09-25
Regulatory Status
RX
Drug Name
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
5MG;6.25MG
Approval Date
2000-09-25
Active Ingredient
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Application Number
75579
Product Number
2
Dosage Form
-
Strength
5MG;6.25MG
Approval Date
2000-09-25
Regulatory Status
RX
Drug Name
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
10MG;6.25MG
Approval Date
2000-09-25
Active Ingredient
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Application Number
75579
Product Number
3
Dosage Form
-
Strength
10MG;6.25MG
Approval Date
2000-09-25
Regulatory Status
RX
Drug Name
BUCAPSOL
Product Number
1
Dosage Form
-
Strength
7.5MG
Approval Date
2025-03-13
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
218628
Product Number
1
Dosage Form
-
Strength
7.5MG
Approval Date
2025-03-13
Regulatory Status
RX
Drug Name
BUCAPSOL
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2025-03-13
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
218628
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2025-03-13
Regulatory Status
RX
Drug Name
BUCAPSOL
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2025-03-13
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
218628
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2025-03-13
Regulatory Status
RX
Drug Name
BUCAPSOL
Product Number
4
Dosage Form
-
Strength
5MG
Approval Date
2026-04-29
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
218628
Product Number
4
Dosage Form
-
Strength
5MG
Approval Date
2026-04-29
Regulatory Status
RX
Drug Name
BUPROPION HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2003-11-25
Active Ingredient
BUPROPION HYDROCHLORIDE
Application Number
75932
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2003-11-25
Regulatory Status
RX
Drug Name
BUPROPION HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2004-03-22
Active Ingredient
BUPROPION HYDROCHLORIDE
Application Number
75932
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2004-03-22
Regulatory Status
RX
Drug Name
BUPROPION HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
2005-06-22
Active Ingredient
BUPROPION HYDROCHLORIDE
Application Number
75932
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
2005-06-22
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2019-04-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
208972
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2019-04-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
7.5MG
Approval Date
2019-04-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
208972
Product Number
2
Dosage Form
-
Strength
7.5MG
Approval Date
2019-04-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2019-04-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
208972
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2019-04-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2019-04-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
208972
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2019-04-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
30MG
Approval Date
2019-04-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
208972
Product Number
5
Dosage Form
-
Strength
30MG
Approval Date
2019-04-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
2.5MG
Approval Date
2026-05-13
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
208972
Product Number
6
Dosage Form
-
Strength
2.5MG
Approval Date
2026-05-13
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
7
Dosage Form
-
Strength
12.5MG
Approval Date
2026-05-13
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
208972
Product Number
7
Dosage Form
-
Strength
12.5MG
Approval Date
2026-05-13
Regulatory Status
RX
Drug Name
CAPASTAT SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
CAPREOMYCIN SULFATE
Application Number
50095
Product Number
1
Dosage Form
-
Strength
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
CARBOPLATIN
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2009-07-29
Active Ingredient
CARBOPLATIN
Application Number
90475
Product Number
1
Dosage Form
-
Strength
50MG/5ML (10MG/ML)
Approval Date
2009-07-29
Regulatory Status
RX
Drug Name
CARBOPLATIN
Product Number
2
Dosage Form
-
Strength
150MG/15ML (10MG/ML)
Approval Date
2009-07-29
Active Ingredient
CARBOPLATIN
Application Number
90475
Product Number
2
Dosage Form
-
Strength
150MG/15ML (10MG/ML)
Approval Date
2009-07-29
Regulatory Status
RX
Drug Name
CARBOPLATIN
Product Number
3
Dosage Form
-
Strength
450MG/45ML (10MG/ML)
Approval Date
2009-07-29
Active Ingredient
CARBOPLATIN
Application Number
90475
Product Number
3
Dosage Form
-
Strength
450MG/45ML (10MG/ML)
Approval Date
2009-07-29
Regulatory Status
RX
Drug Name
CARBOPLATIN
Product Number
2
Dosage Form
-
Strength
600MG/60ML (10MG/ML)
Approval Date
2010-07-28
Active Ingredient
CARBOPLATIN
Application Number
91268
Product Number
2
Dosage Form
-
Strength
600MG/60ML (10MG/ML)
Approval Date
2010-07-28
Regulatory Status
RX
Drug Name
CARISOPRODOL
Product Number
1
Dosage Form
-
Strength
350MG
Approval Date
2000-09-21
Active Ingredient
CARISOPRODOL
Application Number
40397
Product Number
1
Dosage Form
-
Strength
350MG
Approval Date
2000-09-21
Regulatory Status
Discontinued
Drug Name
CEFTRIAXONE
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
2008-01-11
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65305
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE/VIAL
Approval Date
2008-01-11
Regulatory Status
RX
Drug Name
CEFTRIAXONE
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2008-01-11
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65305
Product Number
2
Dosage Form
-
Strength
EQ 500MG BASE/VIAL
Approval Date
2008-01-11
Regulatory Status
RX
Drug Name
CEFTRIAXONE
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2008-01-11
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65305
Product Number
3
Dosage Form
-
Strength
EQ 1GM BASE/VIAL
Approval Date
2008-01-11
Regulatory Status
RX
Drug Name
CEFTRIAXONE
Product Number
4
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2008-01-11
Active Ingredient
CEFTRIAXONE SODIUM
Application Number
65305
Product Number
4
Dosage Form
-
Strength
EQ 2GM BASE/VIAL
Approval Date
2008-01-11
Regulatory Status
RX
Drug Name
CETRORELIX ACETATE
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE/VIAL
Approval Date
2026-04-29
Active Ingredient
CETRORELIX ACETATE
Application Number
218740
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE/VIAL
Approval Date
2026-04-29
Regulatory Status
RX
Drug Name
CHLORAMPHENICOL
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
1982-01-01
Active Ingredient
CHLORAMPHENICOL
Application Number
62042
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
CHOLESTYRAMINE
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
1996-08-15
Active Ingredient
CHOLESTYRAMINE
Application Number
74557
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
1996-08-15
Regulatory Status
RX
Drug Name
CHOLESTYRAMINE
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
1996-08-15
Active Ingredient
CHOLESTYRAMINE
Application Number
74557
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
1996-08-15
Regulatory Status
RX
Drug Name
CHOLESTYRAMINE LIGHT
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
1996-08-15
Active Ingredient
CHOLESTYRAMINE
Application Number
74558
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
1996-08-15
Regulatory Status
RX
Drug Name
CHOLESTYRAMINE LIGHT
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
1996-08-15
Active Ingredient
CHOLESTYRAMINE
Application Number
74558
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
1996-08-15
Regulatory Status
RX
Drug Name
CICLOPIROX
Product Number
1
Dosage Form
-
Strength
8%
Approval Date
2010-02-17
Active Ingredient
CICLOPIROX
Application Number
78975
Product Number
1
Dosage Form
-
Strength
8%
Approval Date
2010-02-17
Regulatory Status
Discontinued
Drug Name
CILOSTAZOL
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2004-11-23
Active Ingredient
CILOSTAZOL
Application Number
77022
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2004-11-23
Regulatory Status
RX
Drug Name
CILOSTAZOL
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2005-03-11
Active Ingredient
CILOSTAZOL
Application Number
77022
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2005-03-11
Regulatory Status
RX
Drug Name
CITALOPRAM HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2004-10-28
Active Ingredient
CITALOPRAM HYDROBROMIDE
Application Number
77036
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2004-10-28
Regulatory Status
Discontinued
Drug Name
CITALOPRAM HYDROBROMIDE
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2004-10-28
Active Ingredient
CITALOPRAM HYDROBROMIDE
Application Number
77036
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2004-10-28
Regulatory Status
Discontinued
Drug Name
CITALOPRAM HYDROBROMIDE
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2004-10-28
Active Ingredient
CITALOPRAM HYDROBROMIDE
Application Number
77036
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2004-10-28
Regulatory Status
Discontinued
Drug Name
CITALOPRAM HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2005-04-29
Active Ingredient
CITALOPRAM HYDROBROMIDE
Application Number
77045
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2005-04-29
Regulatory Status
RX
Drug Name
CITALOPRAM HYDROBROMIDE
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2005-04-29
Active Ingredient
CITALOPRAM HYDROBROMIDE
Application Number
77045
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2005-04-29
Regulatory Status
RX
Drug Name
CITALOPRAM HYDROBROMIDE
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2005-04-29
Active Ingredient
CITALOPRAM HYDROBROMIDE
Application Number
77045
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2005-04-29
Regulatory Status
RX
Drug Name
CLINDAMYCIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2004-03-22
Active Ingredient
CLINDAMYCIN HYDROCHLORIDE
Application Number
65194
Product Number
1
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2004-03-22
Regulatory Status
RX
Drug Name
CLINDAMYCIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2004-03-22
Active Ingredient
CLINDAMYCIN HYDROCHLORIDE
Application Number
65194
Product Number
2
Dosage Form
-
Strength
EQ 300MG BASE
Approval Date
2004-03-22
Regulatory Status
RX
Drug Name
CLINDAMYCIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 1% BASE
Approval Date
2010-06-17
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
65513
Product Number
1
Dosage Form
-
Strength
EQ 1% BASE
Approval Date
2010-06-17
Regulatory Status
RX
Drug Name
CLOBETASOL PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2018-10-26
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
211348
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2018-10-26
Regulatory Status
Discontinued
Drug Name
COGENTIN
Product Number
1
Dosage Form
-
Strength
1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
BENZTROPINE MESYLATE
Application Number
12015
Product Number
1
Dosage Form
-
Strength
1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
COR-OTICIN
Product Number
1
Dosage Form
-
Strength
1.5%;EQ 3.5MG BASE/ML
Approval Date
1982-01-01
Active Ingredient
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
Application Number
60188
Product Number
1
Dosage Form
-
Strength
1.5%;EQ 3.5MG BASE/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
CYANOCOBALAMIN
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1983-11-10
Active Ingredient
CYANOCOBALAMIN
Application Number
87969
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
1983-11-10
Regulatory Status
Discontinued
Drug Name
CYCLOPHOSPHAMIDE
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2024-12-19
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
218644
Product Number
1
Dosage Form
-
Strength
500MG/VIAL
Approval Date
2024-12-19
Regulatory Status
RX
Drug Name
CYCLOPHOSPHAMIDE
Product Number
2
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2024-12-19
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
218644
Product Number
2
Dosage Form
-
Strength
1GM/VIAL
Approval Date
2024-12-19
Regulatory Status
RX
Drug Name
CYCLOPHOSPHAMIDE
Product Number
3
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2024-12-19
Active Ingredient
CYCLOPHOSPHAMIDE
Application Number
218644
Product Number
3
Dosage Form
-
Strength
2GM/VIAL
Approval Date
2024-12-19
Regulatory Status
RX
Drug Name
DEMECLOCYCLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2008-12-01
Active Ingredient
DEMECLOCYCLINE HYDROCHLORIDE
Application Number
65389
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2008-12-01
Regulatory Status
RX
Drug Name
DEMECLOCYCLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2008-12-01
Active Ingredient
DEMECLOCYCLINE HYDROCHLORIDE
Application Number
65389
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2008-12-01
Regulatory Status
RX
Drug Name
DEMECLOCYCLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2015-08-18
Active Ingredient
DEMECLOCYCLINE HYDROCHLORIDE
Application Number
65447
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2015-08-18
Regulatory Status
RX
Drug Name
DEMECLOCYCLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2015-08-18
Active Ingredient
DEMECLOCYCLINE HYDROCHLORIDE
Application Number
65447
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2015-08-18
Regulatory Status
RX
Drug Name
DESOXIMETASONE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2011-03-10
Active Ingredient
DESOXIMETASONE
Application Number
90727
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2011-03-10
Regulatory Status
RX
Drug Name
DESOXIMETASONE
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2014-04-24
Active Ingredient
DESOXIMETASONE
Application Number
201005
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2014-04-24
Regulatory Status
RX
Drug Name
DEXAMETHASONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 4MG PHOSPHATE/ML
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE SODIUM PHOSPHATE
Application Number
84493
Product Number
1
Dosage Form
-
Strength
EQ 4MG PHOSPHATE/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DEXAMETHASONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 0.1% PHOSPHATE
Approval Date
1982-01-01
Active Ingredient
DEXAMETHASONE SODIUM PHOSPHATE
Application Number
84855
Product Number
1
Dosage Form
-
Strength
EQ 0.1% PHOSPHATE
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
1
Dosage Form
-
Strength
1.25MG;1.25MG;1.25MG;1.25MG
Approval Date
2002-06-19
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40444
Product Number
1
Dosage Form
-
Strength
1.25MG;1.25MG;1.25MG;1.25MG
Approval Date
2002-06-19
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
2
Dosage Form
-
Strength
2.5MG;2.5MG;2.5MG;2.5MG
Approval Date
2002-06-19
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40444
Product Number
2
Dosage Form
-
Strength
2.5MG;2.5MG;2.5MG;2.5MG
Approval Date
2002-06-19
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
3
Dosage Form
-
Strength
5MG;5MG;5MG;5MG
Approval Date
2002-06-19
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40444
Product Number
3
Dosage Form
-
Strength
5MG;5MG;5MG;5MG
Approval Date
2002-06-19
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
4
Dosage Form
-
Strength
7.5MG;7.5MG;7.5MG;7.5MG
Approval Date
2002-06-19
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40444
Product Number
4
Dosage Form
-
Strength
7.5MG;7.5MG;7.5MG;7.5MG
Approval Date
2002-06-19
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
5
Dosage Form
-
Strength
1.875MG;1.875MG;1.875MG;1.875MG
Approval Date
2014-11-03
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40444
Product Number
5
Dosage Form
-
Strength
1.875MG;1.875MG;1.875MG;1.875MG
Approval Date
2014-11-03
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
6
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2014-11-03
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40444
Product Number
6
Dosage Form
-
Strength
3.125MG;3.125MG;3.125MG;3.125MG
Approval Date
2014-11-03
Regulatory Status
RX
Drug Name
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Product Number
7
Dosage Form
-
Strength
3.75MG;3.75MG;3.75MG;3.75MG
Approval Date
2014-11-03
Active Ingredient
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Application Number
40444
Product Number
7
Dosage Form
-
Strength
3.75MG;3.75MG;3.75MG;3.75MG
Approval Date
2014-11-03
Regulatory Status
RX
Drug Name
DEXTROAMPHETAMINE SULFATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-03-07
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Application Number
90652
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-03-07
Regulatory Status
Discontinued
Drug Name
DEXTROAMPHETAMINE SULFATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2014-03-07
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Application Number
90652
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2014-03-07
Regulatory Status
Discontinued
Drug Name
DICLOFENAC SODIUM
Product Number
1
Dosage Form
-
Strength
1.5%
Approval Date
2021-01-28
Active Ingredient
DICLOFENAC SODIUM
Application Number
206655
Product Number
1
Dosage Form
-
Strength
1.5%
Approval Date
2021-01-28
Regulatory Status
RX
Drug Name
DIETHYLPROPION HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2008-11-05
Active Ingredient
DIETHYLPROPION HYDROCHLORIDE
Application Number
40828
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2008-11-05
Regulatory Status
Discontinued
Drug Name
DIFLUPREDNATE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2024-05-14
Active Ingredient
DIFLUPREDNATE
Application Number
207284
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2024-05-14
Regulatory Status
RX
Drug Name
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 2% BASE;EQ 0.5% BASE
Approval Date
2014-09-22
Active Ingredient
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
Application Number
203058
Product Number
1
Dosage Form
-
Strength
EQ 2% BASE;EQ 0.5% BASE
Approval Date
2014-09-22
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-10-16
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
210675
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-10-16
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-10-16
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
210675
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-10-16
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2020-10-16
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
210675
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2020-10-16
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2022-03-03
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
210675
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2022-03-03
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2022-03-03
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
210675
Product Number
5
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2022-03-03
Regulatory Status
RX
Drug Name
DOXERCALCIFEROL
Product Number
1
Dosage Form
-
Strength
4MCG/2ML (2MCG/ML)
Approval Date
2015-05-07
Active Ingredient
DOXERCALCIFEROL
Application Number
203929
Product Number
1
Dosage Form
-
Strength
4MCG/2ML (2MCG/ML)
Approval Date
2015-05-07
Regulatory Status
Discontinued
Drug Name
DOXERCALCIFEROL
Product Number
2
Dosage Form
-
Strength
2MCG/ML (2MCG/ML)
Approval Date
2016-03-28
Active Ingredient
DOXERCALCIFEROL
Application Number
203929
Product Number
2
Dosage Form
-
Strength
2MCG/ML (2MCG/ML)
Approval Date
2016-03-28
Regulatory Status
Discontinued
Drug Name
DOXYCYCLINE HYCLATE
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
1982-11-08
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62269
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
1982-11-08
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
1983-10-05
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
62269
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
1983-10-05
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2005-05-13
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
65182
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2005-05-13
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2020-12-16
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
214207
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2020-12-16
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
2
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2020-12-16
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
214207
Product Number
2
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2020-12-16
Regulatory Status
RX
Drug Name
EPINASTINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2017-05-05
Active Ingredient
EPINASTINE HYDROCHLORIDE
Application Number
204055
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2017-05-05
Regulatory Status
Discontinued
Drug Name
EPIRUBICIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/25ML (2MG/ML)
Approval Date
2009-06-24
Active Ingredient
EPIRUBICIN HYDROCHLORIDE
Application Number
90163
Product Number
1
Dosage Form
-
Strength
50MG/25ML (2MG/ML)
Approval Date
2009-06-24
Regulatory Status
RX
Drug Name
ERYTHRO-STATIN
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1996-10-22
Active Ingredient
ERYTHROMYCIN
Application Number
64101
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
1996-10-22
Regulatory Status
Discontinued
Drug Name
ERYTHROMYCIN
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2010-05-12
Active Ingredient
ERYTHROMYCIN
Application Number
90215
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2010-05-12
Regulatory Status
RX
Drug Name
ESOMEPRAZOLE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2025-01-08
Active Ingredient
ESOMEPRAZOLE SODIUM
Application Number
214046
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2025-01-08
Regulatory Status
RX
Drug Name
ESTRADIOL
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1998-12-29
Active Ingredient
ESTRADIOL
Application Number
40275
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1998-12-29
Regulatory Status
RX
Drug Name
ESTRADIOL
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1998-12-29
Active Ingredient
ESTRADIOL
Application Number
40275
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1998-12-29
Regulatory Status
RX
Drug Name
ESTRADIOL
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1998-12-29
Active Ingredient
ESTRADIOL
Application Number
40275
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1998-12-29
Regulatory Status
RX
Drug Name
ETHAMBUTOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1999-11-30
Active Ingredient
ETHAMBUTOL HYDROCHLORIDE
Application Number
75095
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1999-11-30
Regulatory Status
RX
Drug Name
ETHAMBUTOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
400MG
Approval Date
1999-11-30
Active Ingredient
ETHAMBUTOL HYDROCHLORIDE
Application Number
75095
Product Number
2
Dosage Form
-
Strength
400MG
Approval Date
1999-11-30
Regulatory Status
RX
Drug Name
ETHOSUXIMIDE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2008-05-28
Active Ingredient
ETHOSUXIMIDE
Application Number
40686
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2008-05-28
Regulatory Status
RX
Drug Name
FAMOTIDINE
Product Number
1
Dosage Form
-
Strength
40MG/5ML
Approval Date
2024-10-16
Active Ingredient
FAMOTIDINE
Application Number
218344
Product Number
1
Dosage Form
-
Strength
40MG/5ML
Approval Date
2024-10-16
Regulatory Status
RX
Drug Name
FAMOTIDINE PRESERVATIVE FREE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-11-27
Active Ingredient
FAMOTIDINE
Application Number
76324
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-11-27
Regulatory Status
Discontinued
Drug Name
FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK)
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-11-27
Active Ingredient
FAMOTIDINE
Application Number
76322
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
2002-11-27
Regulatory Status
Discontinued
Drug Name
FLAVOXATE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2005-11-30
Active Ingredient
FLAVOXATE HYDROCHLORIDE
Application Number
76835
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2005-11-30
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
1982-01-01
Active Ingredient
FUROSEMIDE
Application Number
18569
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
1982-01-01
Active Ingredient
FUROSEMIDE
Application Number
18569
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
5
Dosage Form
-
Strength
80MG
Approval Date
1984-08-14
Active Ingredient
FUROSEMIDE
Application Number
18569
Product Number
5
Dosage Form
-
Strength
80MG
Approval Date
1984-08-14
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
1984-07-30
Active Ingredient
FUROSEMIDE
Application Number
18750
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
1984-07-30
Regulatory Status
Discontinued
Drug Name
GABAPENTIN
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2024-02-26
Active Ingredient
GABAPENTIN
Application Number
216252
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2024-02-26
Regulatory Status
RX
Drug Name
GABAPENTIN
Product Number
2
Dosage Form
-
Strength
600MG
Approval Date
2024-02-26
Active Ingredient
GABAPENTIN
Application Number
216252
Product Number
2
Dosage Form
-
Strength
600MG
Approval Date
2024-02-26
Regulatory Status
RX
Drug Name
GEMFIBROZIL
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2007-03-26
Active Ingredient
GEMFIBROZIL
Application Number
78012
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2007-03-26
Regulatory Status
RX
Drug Name
GENTAMICIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 0.3% BASE
Approval Date
1987-01-08
Active Ingredient
GENTAMICIN SULFATE
Application Number
62635
Product Number
1
Dosage Form
-
Strength
EQ 0.3% BASE
Approval Date
1987-01-08
Regulatory Status
Discontinued
Drug Name
GLIMEPIRIDE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2005-10-06
Active Ingredient
GLIMEPIRIDE
Application Number
77274
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2005-10-06
Regulatory Status
Discontinued
Drug Name
GLIMEPIRIDE
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2005-10-06
Active Ingredient
GLIMEPIRIDE
Application Number
77274
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2005-10-06
Regulatory Status
Discontinued
Drug Name
GLIMEPIRIDE
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2005-10-06
Active Ingredient
GLIMEPIRIDE
Application Number
77274
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2005-10-06
Regulatory Status
Discontinued
Drug Name
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
2.5MG;250MG
Approval Date
2005-10-27
Active Ingredient
GLIPIZIDE; METFORMIN HYDROCHLORIDE
Application Number
77507
Product Number
1
Dosage Form
-
Strength
2.5MG;250MG
Approval Date
2005-10-27
Regulatory Status
RX
Drug Name
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2.5MG;500MG
Approval Date
2005-10-27
Active Ingredient
GLIPIZIDE; METFORMIN HYDROCHLORIDE
Application Number
77507
Product Number
2
Dosage Form
-
Strength
2.5MG;500MG
Approval Date
2005-10-27
Regulatory Status
RX
Drug Name
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
5MG;500MG
Approval Date
2005-10-27
Active Ingredient
GLIPIZIDE; METFORMIN HYDROCHLORIDE
Application Number
77507
Product Number
3
Dosage Form
-
Strength
5MG;500MG
Approval Date
2005-10-27
Regulatory Status
RX
Drug Name
GLYBURIDE
Product Number
1
Dosage Form
-
Strength
1.25MG
Approval Date
2002-06-27
Active Ingredient
GLYBURIDE
Application Number
76257
Product Number
1
Dosage Form
-
Strength
1.25MG
Approval Date
2002-06-27
Regulatory Status
RX
Drug Name
GLYBURIDE
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2002-06-27
Active Ingredient
GLYBURIDE
Application Number
76257
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2002-06-27
Regulatory Status
RX
Drug Name
GLYBURIDE
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2002-06-27
Active Ingredient
GLYBURIDE
Application Number
76257
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2002-06-27
Regulatory Status
RX
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2007-12-31
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
78260
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2007-12-31
Regulatory Status
Discontinued
Drug Name
GRANISETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
Approval Date
2009-09-10
Active Ingredient
GRANISETRON HYDROCHLORIDE
Application Number
79119
Product Number
1
Dosage Form
-
Strength
EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
Approval Date
2009-09-10
Regulatory Status
Discontinued
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
1997-02-28
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
74673
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
1997-02-28
Regulatory Status
RX
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
1997-02-28
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
74673
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
1997-02-28
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2017-09-06
Active Ingredient
HALOPERIDOL LACTATE
Application Number
204849
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2017-09-06
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
1
Dosage Form
-
Strength
1,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17486
Product Number
1
Dosage Form
-
Strength
1,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
2
Dosage Form
-
Strength
5,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17486
Product Number
2
Dosage Form
-
Strength
5,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
3
Dosage Form
-
Strength
10,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17486
Product Number
3
Dosage Form
-
Strength
10,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
4
Dosage Form
-
Strength
20,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17486
Product Number
4
Dosage Form
-
Strength
20,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HEPARIN SODIUM
Product Number
5
Dosage Form
-
Strength
40,000 UNITS/ML
Approval Date
1982-01-01
Active Ingredient
HEPARIN SODIUM
Application Number
17486
Product Number
5
Dosage Form
-
Strength
40,000 UNITS/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
2018-03-30
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
203863
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
2018-03-30
Regulatory Status
RX
Drug Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Number
2
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2018-03-30
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
203863
Product Number
2
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2018-03-30
Regulatory Status
RX
Drug Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Number
3
Dosage Form
-
Strength
325MG;10MG
Approval Date
2018-03-30
Active Ingredient
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Application Number
203863
Product Number
3
Dosage Form
-
Strength
325MG;10MG
Approval Date
2018-03-30
Regulatory Status
RX
Drug Name
HYDROCORTISONE ACETATE
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Active Ingredient
HYDROCORTISONE ACETATE
Application Number
9637
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HYDROCORTISONE ACETATE
Product Number
2
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
HYDROCORTISONE ACETATE
Application Number
9637
Product Number
2
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HYDROXYPROGESTERONE CAPROATE
Product Number
1
Dosage Form
-
Strength
125MG/ML
Approval Date
1982-01-01
Active Ingredient
HYDROXYPROGESTERONE CAPROATE
Application Number
18004
Product Number
1
Dosage Form
-
Strength
125MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
HYDROXYZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2004-12-28
Active Ingredient
HYDROXYZINE HYDROCHLORIDE
Application Number
40604
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2004-12-28
Regulatory Status
RX
Drug Name
HYDROXYZINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2004-12-28
Active Ingredient
HYDROXYZINE HYDROCHLORIDE
Application Number
40604
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2004-12-28
Regulatory Status
RX
Drug Name
HYDROXYZINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
2004-12-28
Active Ingredient
HYDROXYZINE HYDROCHLORIDE
Application Number
40604
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
2004-12-28
Regulatory Status
RX
Drug Name
INNOVAR
Product Number
1
Dosage Form
-
Strength
2.5MG/ML;EQ 0.05MG BASE/ML
Approval Date
1982-01-01
Active Ingredient
DROPERIDOL; FENTANYL CITRATE
Application Number
16049
Product Number
1
Dosage Form
-
Strength
2.5MG/ML;EQ 0.05MG BASE/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
IRINOTECAN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
40MG/2ML (20MG/ML)
Approval Date
2009-09-16
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Application Number
90726
Product Number
1
Dosage Form
-
Strength
40MG/2ML (20MG/ML)
Approval Date
2009-09-16
Regulatory Status
RX
Drug Name
IRINOTECAN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2009-09-16
Active Ingredient
IRINOTECAN HYDROCHLORIDE
Application Number
90726
Product Number
2
Dosage Form
-
Strength
100MG/5ML (20MG/ML)
Approval Date
2009-09-16
Regulatory Status
RX
Drug Name
ISONIAZID
Product Number
2
Dosage Form
-
Strength
100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
ISONIAZID
Application Number
8678
Product Number
2
Dosage Form
-
Strength
100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
ISONIAZID
Product Number
3
Dosage Form
-
Strength
300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
ISONIAZID
Application Number
8678
Product Number
3
Dosage Form
-
Strength
300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
IVERMECTIN
Product Number
1
Dosage Form
-
Strength
3MG
Approval Date
2025-09-09
Active Ingredient
IVERMECTIN
Application Number
218805
Product Number
1
Dosage Form
-
Strength
3MG
Approval Date
2025-09-09
Regulatory Status
RX
Drug Name
KETOROLAC TROMETHAMINE
Product Number
1
Dosage Form
-
Strength
0.4%
Approval Date
2009-11-05
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
78399
Product Number
1
Dosage Form
-
Strength
0.4%
Approval Date
2009-11-05
Regulatory Status
Discontinued
Drug Name
KETOROLAC TROMETHAMINE
Product Number
1
Dosage Form
-
Strength
0.45%
Approval Date
2014-02-10
Active Ingredient
KETOROLAC TROMETHAMINE
Application Number
203376
Product Number
1
Dosage Form
-
Strength
0.45%
Approval Date
2014-02-10
Regulatory Status
Discontinued
Drug Name
KLAYESTA
Product Number
1
Dosage Form
-
Strength
100,000 UNITS/GM
Approval Date
2018-04-30
Active Ingredient
NYSTATIN
Application Number
210532
Product Number
1
Dosage Form
-
Strength
100,000 UNITS/GM
Approval Date
2018-04-30
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2020-09-30
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
212990
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2020-09-30
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2020-09-30
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
212990
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2020-09-30
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2020-09-30
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
212990
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
2020-09-30
Regulatory Status
RX
Drug Name
LAMIVUDINE AND ZIDOVUDINE
Product Number
1
Dosage Form
-
Strength
150MG;300MG
Approval Date
2018-04-10
Active Ingredient
LAMIVUDINE; ZIDOVUDINE
Application Number
206375
Product Number
1
Dosage Form
-
Strength
150MG;300MG
Approval Date
2018-04-10
Regulatory Status
RX
Drug Name
LATANOPROST
Product Number
1
Dosage Form
-
Strength
0.005%
Approval Date
2011-07-19
Active Ingredient
LATANOPROST
Application Number
90887
Product Number
1
Dosage Form
-
Strength
0.005%
Approval Date
2011-07-19
Regulatory Status
Discontinued
Drug Name
LEUCOVORIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
1997-08-28
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
74544
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
1997-08-28
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
1997-08-28
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
74544
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
1997-08-28
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2021-05-19
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
74544
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2021-05-19
Regulatory Status
RX
Drug Name
LEUCOVORIN CALCIUM
Product Number
4
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
2021-05-19
Active Ingredient
LEUCOVORIN CALCIUM
Application Number
74544
Product Number
4
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
2021-05-19
Regulatory Status
RX
Drug Name
LEVETIRACETAM
Product Number
1
Dosage Form
-
Strength
500MG/5ML (100MG/ML)
Approval Date
2018-05-04
Active Ingredient
LEVETIRACETAM
Application Number
209934
Product Number
1
Dosage Form
-
Strength
500MG/5ML (100MG/ML)
Approval Date
2018-05-04
Regulatory Status
Discontinued
Drug Name
LIDOCAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1982-01-01
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
85037
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
LIDOCAINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
1982-01-01
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
85037
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;10MG
Approval Date
2002-07-01
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
75926
Product Number
1
Dosage Form
-
Strength
12.5MG;10MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;20MG
Approval Date
2002-07-01
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
75926
Product Number
2
Dosage Form
-
Strength
12.5MG;20MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;20MG
Approval Date
2002-07-01
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
75926
Product Number
3
Dosage Form
-
Strength
25MG;20MG
Approval Date
2002-07-01
Regulatory Status
Discontinued
Drug Name
LORAZEPAM
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-07-23
Active Ingredient
LORAZEPAM
Application Number
74974
Product Number
1
Dosage Form
-
Strength
2MG/ML
Approval Date
1998-07-23
Regulatory Status
Discontinued
Drug Name
LOVASTATIN
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2001-12-17
Active Ingredient
LOVASTATIN
Application Number
75636
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2001-12-17
Regulatory Status
RX
Drug Name
LOVASTATIN
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2001-12-17
Active Ingredient
LOVASTATIN
Application Number
75636
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2001-12-17
Regulatory Status
RX
Drug Name
LOVASTATIN
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2001-12-17
Active Ingredient
LOVASTATIN
Application Number
75636
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2001-12-17
Regulatory Status
RX
Drug Name
MECLIZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2012-04-13
Active Ingredient
MECLIZINE HYDROCHLORIDE
Application Number
200294
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2012-04-13
Regulatory Status
RX
Drug Name
MECLIZINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2012-04-13
Active Ingredient
MECLIZINE HYDROCHLORIDE
Application Number
200294
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2012-04-13
Regulatory Status
RX
Drug Name
MEPERIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1999-05-28
Active Ingredient
MEPERIDINE HYDROCHLORIDE
Application Number
40331
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1999-05-28
Regulatory Status
RX
Drug Name
MEPERIDINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
1999-05-28
Active Ingredient
MEPERIDINE HYDROCHLORIDE
Application Number
40331
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
1999-05-28
Regulatory Status
RX
Drug Name
METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2002-01-25
Active Ingredient
METFORMIN HYDROCHLORIDE
Application Number
75965
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2002-01-25
Regulatory Status
RX
Drug Name
METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
850MG
Approval Date
2002-01-25
Active Ingredient
METFORMIN HYDROCHLORIDE
Application Number
75965
Product Number
2
Dosage Form
-
Strength
850MG
Approval Date
2002-01-25
Regulatory Status
RX
Drug Name
METFORMIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
1GM
Approval Date
2002-01-25
Active Ingredient
METFORMIN HYDROCHLORIDE
Application Number
75965
Product Number
3
Dosage Form
-
Strength
1GM
Approval Date
2002-01-25
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-08-18
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
90065
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-08-18
Regulatory Status
RX
Drug Name
METHADONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-08-18
Active Ingredient
METHADONE HYDROCHLORIDE
Application Number
90065
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-08-18
Regulatory Status
RX
Drug Name
METHOTREXATE SODIUM
Product Number
1
Dosage Form
-
Strength
0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML
Approval Date
1999-02-26
Active Ingredient
CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
Application Number
20079
Product Number
1
Dosage Form
-
Strength
0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML
Approval Date
1999-02-26
Regulatory Status
Discontinued
Drug Name
METHYLPREDNISOLONE ACETATE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
1982-10-20
Active Ingredient
METHYLPREDNISOLONE ACETATE
Application Number
86903
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
1982-10-20
Regulatory Status
Discontinued
Drug Name
METHYLPREDNISOLONE ACETATE
Product Number
2
Dosage Form
-
Strength
80MG/ML
Approval Date
1982-10-20
Active Ingredient
METHYLPREDNISOLONE ACETATE
Application Number
86903
Product Number
2
Dosage Form
-
Strength
80MG/ML
Approval Date
1982-10-20
Regulatory Status
Discontinued
Drug Name
MIDAZOLAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-30
Active Ingredient
MIDAZOLAM HYDROCHLORIDE
Application Number
75481
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2000-06-30
Regulatory Status
Discontinued
Drug Name
MOLINDONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-03-20
Active Ingredient
MOLINDONE HYDROCHLORIDE
Application Number
90453
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-03-20
Regulatory Status
RX
Drug Name
MOLINDONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-03-20
Active Ingredient
MOLINDONE HYDROCHLORIDE
Application Number
90453
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-03-20
Regulatory Status
RX
Drug Name
MOLINDONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
2015-03-20
Active Ingredient
MOLINDONE HYDROCHLORIDE
Application Number
90453
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
2015-03-20
Regulatory Status
RX
Drug Name
MORPHINE SULFATE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2016-06-23
Active Ingredient
MORPHINE SULFATE
Application Number
91357
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2016-06-23
Regulatory Status
Discontinued
Drug Name
MORPHINE SULFATE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2016-06-23
Active Ingredient
MORPHINE SULFATE
Application Number
91357
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2016-06-23
Regulatory Status
Discontinued
Drug Name
MORPHINE SULFATE
Product Number
3
Dosage Form
-
Strength
60MG
Approval Date
2016-06-23
Active Ingredient
MORPHINE SULFATE
Application Number
91357
Product Number
3
Dosage Form
-
Strength
60MG
Approval Date
2016-06-23
Regulatory Status
Discontinued
Drug Name
MORPHINE SULFATE
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2016-06-23
Active Ingredient
MORPHINE SULFATE
Application Number
91357
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2016-06-23
Regulatory Status
Discontinued
Drug Name
MORPHINE SULFATE
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2016-06-23
Active Ingredient
MORPHINE SULFATE
Application Number
91357
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2016-06-23
Regulatory Status
Discontinued
Drug Name
MOXIFLOXACIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
2017-11-09
Active Ingredient
MOXIFLOXACIN HYDROCHLORIDE
Application Number
202916
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
2017-11-09
Regulatory Status
Discontinued
Drug Name
NABUMETONE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2002-02-25
Active Ingredient
NABUMETONE
Application Number
75590
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2002-02-25
Regulatory Status
Discontinued
Drug Name
NABUMETONE
Product Number
2
Dosage Form
-
Strength
750MG
Approval Date
2002-02-25
Active Ingredient
NABUMETONE
Application Number
75590
Product Number
2
Dosage Form
-
Strength
750MG
Approval Date
2002-02-25
Regulatory Status
Discontinued
Drug Name
NANDROLONE DECANOATE
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1983-09-28
Active Ingredient
NANDROLONE DECANOATE
Application Number
87519
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1983-09-28
Regulatory Status
Discontinued
Drug Name
NEDOCROMIL SODIUM
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2012-08-22
Active Ingredient
NEDOCROMIL SODIUM
Application Number
90638
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2012-08-22
Regulatory Status
Discontinued
Drug Name
NEMBUTAL SODIUM
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1982-01-01
Active Ingredient
PENTOBARBITAL SODIUM
Application Number
83245
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
NEMBUTAL SODIUM
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Active Ingredient
PENTOBARBITAL SODIUM
Application Number
84093
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
NEMBUTAL SODIUM
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
1982-01-01
Active Ingredient
PENTOBARBITAL SODIUM
Application Number
84095
Product Number
1
Dosage Form
-
Strength
30MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
NICARDIPINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1998-03-19
Active Ingredient
NICARDIPINE HYDROCHLORIDE
Application Number
74928
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1998-03-19
Regulatory Status
RX
Drug Name
NICARDIPINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
1998-03-19
Active Ingredient
NICARDIPINE HYDROCHLORIDE
Application Number
74928
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
1998-03-19
Regulatory Status
RX
Drug Name
NIZATIDINE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2002-07-05
Active Ingredient
NIZATIDINE
Application Number
76178
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2002-07-05
Regulatory Status
RX
Drug Name
NIZATIDINE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2002-07-05
Active Ingredient
NIZATIDINE
Application Number
76178
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2002-07-05
Regulatory Status
RX
Drug Name
NYSTATIN AND TRIAMCINOLONE ACETONIDE
Product Number
1
Dosage Form
-
Strength
100,000 UNITS/GM;0.1%
Approval Date
2017-08-04
Active Ingredient
NYSTATIN; TRIAMCINOLONE ACETONIDE
Application Number
207217
Product Number
1
Dosage Form
-
Strength
100,000 UNITS/GM;0.1%
Approval Date
2017-08-04
Regulatory Status
RX
Drug Name
OCUSERT PILO-20
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1982-01-01
Active Ingredient
PILOCARPINE
Application Number
17431
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
OCUSERT PILO-40
Product Number
1
Dosage Form
-
Strength
11MG
Approval Date
1982-01-01
Active Ingredient
PILOCARPINE
Application Number
17548
Product Number
1
Dosage Form
-
Strength
11MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
OFLOXACIN
Product Number
1
Dosage Form
-
Strength
0.3%
Approval Date
2004-05-14
Active Ingredient
OFLOXACIN
Application Number
76615
Product Number
1
Dosage Form
-
Strength
0.3%
Approval Date
2004-05-14
Regulatory Status
Discontinued
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE;EQ 6MG BASE
Approval Date
2012-11-16
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
78901
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE;EQ 6MG BASE
Approval Date
2012-11-16
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE;EQ 6MG BASE
Approval Date
2012-11-16
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
78901
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE;EQ 6MG BASE
Approval Date
2012-11-16
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 25MG BASE;EQ 12MG BASE
Approval Date
2012-11-16
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
78901
Product Number
3
Dosage Form
-
Strength
EQ 25MG BASE;EQ 12MG BASE
Approval Date
2012-11-16
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE;EQ 12MG BASE
Approval Date
2012-11-16
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
78901
Product Number
4
Dosage Form
-
Strength
EQ 50MG BASE;EQ 12MG BASE
Approval Date
2012-11-16
Regulatory Status
RX
Drug Name
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
EQ 25MG BASE;EQ 3MG BASE
Approval Date
2012-11-16
Active Ingredient
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Application Number
78901
Product Number
5
Dosage Form
-
Strength
EQ 25MG BASE;EQ 3MG BASE
Approval Date
2012-11-16
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2021-10-01
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
215208
Product Number
1
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2021-10-01
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
2
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2021-10-01
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
215208
Product Number
2
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2021-10-01
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
3
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2021-10-01
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
215208
Product Number
3
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2021-10-01
Regulatory Status
RX
Drug Name
OSELTAMIVIR PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2023-02-14
Active Ingredient
OSELTAMIVIR PHOSPHATE
Application Number
215538
Product Number
1
Dosage Form
-
Strength
EQ 6MG BASE/ML
Approval Date
2023-02-14
Regulatory Status
RX
Drug Name
OXAZEPAM
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
1988-04-19
Active Ingredient
OXAZEPAM
Application Number
71756
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
1988-04-19
Regulatory Status
RX
Drug Name
OXAZEPAM
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1988-04-19
Active Ingredient
OXAZEPAM
Application Number
71756
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1988-04-19
Regulatory Status
RX
Drug Name
OXAZEPAM
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
1988-04-19
Active Ingredient
OXAZEPAM
Application Number
71756
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
1988-04-19
Regulatory Status
RX
Drug Name
OXCARBAZEPINE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2026-03-02
Active Ingredient
OXCARBAZEPINE
Application Number
219556
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2026-03-02
Regulatory Status
RX
Drug Name
OXCARBAZEPINE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2026-03-02
Active Ingredient
OXCARBAZEPINE
Application Number
219556
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2026-03-02
Regulatory Status
RX
Drug Name
OXCARBAZEPINE
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2026-03-02
Active Ingredient
OXCARBAZEPINE
Application Number
219556
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2026-03-02
Regulatory Status
RX
Drug Name
OXYCODONE AND ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
2018-07-02
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
203864
Product Number
1
Dosage Form
-
Strength
325MG;5MG
Approval Date
2018-07-02
Regulatory Status
RX
Drug Name
OXYCODONE AND ACETAMINOPHEN
Product Number
2
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2018-07-02
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
203864
Product Number
2
Dosage Form
-
Strength
325MG;7.5MG
Approval Date
2018-07-02
Regulatory Status
RX
Drug Name
OXYCODONE AND ACETAMINOPHEN
Product Number
3
Dosage Form
-
Strength
325MG;10MG
Approval Date
2018-07-02
Active Ingredient
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Application Number
203864
Product Number
3
Dosage Form
-
Strength
325MG;10MG
Approval Date
2018-07-02
Regulatory Status
RX
Drug Name
OXYCODONE AND ASPIRIN
Product Number
1
Dosage Form
-
Strength
325MG;4.8355MG
Approval Date
2020-07-16
Active Ingredient
ASPIRIN; OXYCODONE HYDROCHLORIDE
Application Number
40910
Product Number
1
Dosage Form
-
Strength
325MG;4.8355MG
Approval Date
2020-07-16
Regulatory Status
Discontinued
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2009-08-24
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
90895
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2009-08-24
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2009-08-24
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
90895
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2009-08-24
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2009-08-24
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
90895
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2009-08-24
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-09-22
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
202662
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-09-22
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-09-22
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
202662
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-09-22
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2015-09-22
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
202662
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2015-09-22
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
2015-09-22
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
202662
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
2015-09-22
Regulatory Status
RX
Drug Name
OXYCODONE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2017-04-27
Active Ingredient
OXYCODONE HYDROCHLORIDE
Application Number
202662
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2017-04-27
Regulatory Status
RX
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-12-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
201187
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-12-15
Regulatory Status
RX
Drug Name
OXYMORPHONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2014-12-15
Active Ingredient
OXYMORPHONE HYDROCHLORIDE
Application Number
201187
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2014-12-15
Regulatory Status
RX
Drug Name
PANTOPRAZOLE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2012-11-08
Active Ingredient
PANTOPRAZOLE SODIUM
Application Number
79197
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/VIAL
Approval Date
2012-11-08
Regulatory Status
RX
Drug Name
PAREMYD
Product Number
1
Dosage Form
-
Strength
1%;0.25%
Approval Date
1992-01-30
Active Ingredient
HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE
Application Number
19261
Product Number
1
Dosage Form
-
Strength
1%;0.25%
Approval Date
1992-01-30
Regulatory Status
Discontinued
Drug Name
PARICALCITOL
Product Number
1
Dosage Form
-
Strength
0.01MG/2ML (0.005MG/ML)
Approval Date
2017-10-16
Active Ingredient
PARICALCITOL
Application Number
207692
Product Number
1
Dosage Form
-
Strength
0.01MG/2ML (0.005MG/ML)
Approval Date
2017-10-16
Regulatory Status
Discontinued
Drug Name
PAROXETINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG BASE
Approval Date
2021-08-11
Active Ingredient
PAROXETINE HYDROCHLORIDE
Application Number
213612
Product Number
1
Dosage Form
-
Strength
EQ 12.5MG BASE
Approval Date
2021-08-11
Regulatory Status
Discontinued
Drug Name
PAROXETINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2021-08-11
Active Ingredient
PAROXETINE HYDROCHLORIDE
Application Number
213612
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2021-08-11
Regulatory Status
Discontinued
Drug Name
PAROXETINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 37.5MG BASE
Approval Date
2022-05-26
Active Ingredient
PAROXETINE HYDROCHLORIDE
Application Number
213612
Product Number
3
Dosage Form
-
Strength
EQ 37.5MG BASE
Approval Date
2022-05-26
Regulatory Status
Discontinued
Drug Name
PHENYTOIN
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2014-11-28
Active Ingredient
PHENYTOIN
Application Number
40884
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2014-11-28
Regulatory Status
RX
Drug Name
POTASSIUM CHLORIDE
Product Number
1
Dosage Form
-
Strength
2MEQ/ML
Approval Date
1985-09-05
Active Ingredient
POTASSIUM CHLORIDE
Application Number
88286
Product Number
1
Dosage Form
-
Strength
2MEQ/ML
Approval Date
1985-09-05
Regulatory Status
Discontinued
Drug Name
POTASSIUM CHLORIDE
Product Number
1
Dosage Form
-
Strength
20MEQ
Approval Date
2018-11-23
Active Ingredient
POTASSIUM CHLORIDE
Application Number
210200
Product Number
1
Dosage Form
-
Strength
20MEQ
Approval Date
2018-11-23
Regulatory Status
RX
Drug Name
PREDAMIDE
Product Number
1
Dosage Form
-
Strength
0.5%;10%
Approval Date
1983-07-29
Active Ingredient
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
Application Number
88059
Product Number
1
Dosage Form
-
Strength
0.5%;10%
Approval Date
1983-07-29
Regulatory Status
Discontinued
Drug Name
PREDNISOLONE ACETATE
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Active Ingredient
PREDNISOLONE ACETATE
Application Number
83032
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PREDNISOLONE ACETATE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
PREDNISOLONE ACETATE
Application Number
84492
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PREDNISOLONE SODIUM PHOSPHATE
Product Number
1
Dosage Form
-
Strength
EQ 0.11% PHOSPHATE
Approval Date
1982-01-01
Active Ingredient
PREDNISOLONE SODIUM PHOSPHATE
Application Number
83358
Product Number
1
Dosage Form
-
Strength
EQ 0.11% PHOSPHATE
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PREDNISOLONE SODIUM PHOSPHATE
Product Number
2
Dosage Form
-
Strength
EQ 0.9% PHOSPHATE
Approval Date
1982-01-01
Active Ingredient
PREDNISOLONE SODIUM PHOSPHATE
Application Number
83358
Product Number
2
Dosage Form
-
Strength
EQ 0.9% PHOSPHATE
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
1
Dosage Form
-
Strength
82.5MG
Approval Date
2023-06-01
Active Ingredient
PREGABALIN
Application Number
214496
Product Number
1
Dosage Form
-
Strength
82.5MG
Approval Date
2023-06-01
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
2
Dosage Form
-
Strength
165MG
Approval Date
2023-06-01
Active Ingredient
PREGABALIN
Application Number
214496
Product Number
2
Dosage Form
-
Strength
165MG
Approval Date
2023-06-01
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
3
Dosage Form
-
Strength
330MG
Approval Date
2023-06-01
Active Ingredient
PREGABALIN
Application Number
214496
Product Number
3
Dosage Form
-
Strength
330MG
Approval Date
2023-06-01
Regulatory Status
RX
Drug Name
PROMETHAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Active Ingredient
PROMETHAZINE HYDROCHLORIDE
Application Number
83955
Product Number
1
Dosage Form
-
Strength
50MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PROMETHAZINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Active Ingredient
PROMETHAZINE HYDROCHLORIDE
Application Number
83955
Product Number
2
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PROTRIPTYLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2012-11-19
Active Ingredient
PROTRIPTYLINE HYDROCHLORIDE
Application Number
202220
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2012-11-19
Regulatory Status
RX
Drug Name
PROTRIPTYLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2012-11-19
Active Ingredient
PROTRIPTYLINE HYDROCHLORIDE
Application Number
202220
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2012-11-19
Regulatory Status
RX
Drug Name
PYRIDOXINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1982-10-01
Active Ingredient
PYRIDOXINE HYDROCHLORIDE
Application Number
87967
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1982-10-01
Regulatory Status
Discontinued
Drug Name
QUINIDINE SULFATE
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1983-09-26
Active Ingredient
QUINIDINE SULFATE
Application Number
88072
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1983-09-26
Regulatory Status
RX
Drug Name
QUINIDINE SULFATE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
1982-01-01
Active Ingredient
QUINIDINE SULFATE
Application Number
88072
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
RANITIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE/ML
Approval Date
2011-03-22
Active Ingredient
RANITIDINE HYDROCHLORIDE
Application Number
91078
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE/ML
Approval Date
2011-03-22
Regulatory Status
Discontinued
Drug Name
RIFAMPIN
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1997-05-28
Active Ingredient
RIFAMPIN
Application Number
64150
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
1997-05-28
Regulatory Status
RX
Drug Name
RIFAMPIN
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1998-01-02
Active Ingredient
RIFAMPIN
Application Number
64150
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1998-01-02
Regulatory Status
RX
Drug Name
RIFAMPIN
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
2010-09-21
Active Ingredient
RIFAMPIN
Application Number
65502
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
2010-09-21
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
-
Active Ingredient
RIVAROXABAN
Application Number
216255
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RIVAROXABAN
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
-
Active Ingredient
RIVAROXABAN
Application Number
216255
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RIVAROXABAN
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
-
Active Ingredient
RIVAROXABAN
Application Number
216255
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RIVAROXABAN
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
-
Active Ingredient
RIVAROXABAN
Application Number
216255
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE
Approval Date
2008-05-20
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
78230
Product Number
1
Dosage Form
-
Strength
EQ 0.25MG BASE
Approval Date
2008-05-20
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2008-05-20
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
78230
Product Number
2
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2008-05-20
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2008-05-20
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
78230
Product Number
3
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2008-05-20
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2008-05-20
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
78230
Product Number
4
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2008-05-20
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2008-05-20
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
78230
Product Number
5
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2008-05-20
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2008-05-20
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
78230
Product Number
6
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2008-05-20
Regulatory Status
Discontinued
Drug Name
ROPINIROLE HYDROCHLORIDE
Product Number
7
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2008-05-20
Active Ingredient
ROPINIROLE HYDROCHLORIDE
Application Number
78230
Product Number
7
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2008-05-20
Regulatory Status
Discontinued
Drug Name
SEVELAMER CARBONATE
Product Number
1
Dosage Form
-
Strength
800MG
Approval Date
2020-04-09
Active Ingredient
SEVELAMER CARBONATE
Application Number
212970
Product Number
1
Dosage Form
-
Strength
800MG
Approval Date
2020-04-09
Regulatory Status
Discontinued
Drug Name
SODIUM NITROPRUSSIDE
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
2017-05-04
Active Ingredient
SODIUM NITROPRUSSIDE
Application Number
208635
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
2017-05-04
Regulatory Status
Discontinued
Drug Name
SODIUM POLYSTYRENE SULFONATE
Product Number
1
Dosage Form
-
Strength
453.6GM/BOT
Approval Date
2014-03-19
Active Ingredient
SODIUM POLYSTYRENE SULFONATE
Application Number
202333
Product Number
1
Dosage Form
-
Strength
453.6GM/BOT
Approval Date
2014-03-19
Regulatory Status
RX
Drug Name
SODIUM SULFACETAMIDE
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
1982-01-01
Active Ingredient
SULFACETAMIDE SODIUM
Application Number
83021
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
SODIUM SULFACETAMIDE
Product Number
2
Dosage Form
-
Strength
15%
Approval Date
1982-01-01
Active Ingredient
SULFACETAMIDE SODIUM
Application Number
83021
Product Number
2
Dosage Form
-
Strength
15%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
SODIUM SULFACETAMIDE
Product Number
3
Dosage Form
-
Strength
30%
Approval Date
1982-01-01
Active Ingredient
SULFACETAMIDE SODIUM
Application Number
83021
Product Number
3
Dosage Form
-
Strength
30%
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
SOTALOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
80MG
Approval Date
2005-11-04
Active Ingredient
SOTALOL HYDROCHLORIDE
Application Number
77070
Product Number
1
Dosage Form
-
Strength
80MG
Approval Date
2005-11-04
Regulatory Status
RX
Drug Name
SOTALOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
120MG
Approval Date
2005-11-04
Active Ingredient
SOTALOL HYDROCHLORIDE
Application Number
77070
Product Number
2
Dosage Form
-
Strength
120MG
Approval Date
2005-11-04
Regulatory Status
RX
Drug Name
SOTALOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
160MG
Approval Date
2005-11-04
Active Ingredient
SOTALOL HYDROCHLORIDE
Application Number
77070
Product Number
3
Dosage Form
-
Strength
160MG
Approval Date
2005-11-04
Regulatory Status
RX
Drug Name
SULFACETAMIDE SODIUM
Product Number
1
Dosage Form
-
Strength
30%
Approval Date
1999-05-25
Active Ingredient
SULFACETAMIDE SODIUM
Application Number
40216
Product Number
1
Dosage Form
-
Strength
30%
Approval Date
1999-05-25
Regulatory Status
Discontinued
Drug Name
SULFADIAZINE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1994-07-29
Active Ingredient
SULFADIAZINE
Application Number
40091
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1994-07-29
Regulatory Status
RX
Drug Name
SULFASALAZINE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Active Ingredient
SULFASALAZINE
Application Number
86184
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
SULINDAC
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1991-03-25
Active Ingredient
SULINDAC
Application Number
72711
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1991-03-25
Regulatory Status
RX
Drug Name
SULINDAC
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1991-03-25
Active Ingredient
SULINDAC
Application Number
72711
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1991-03-25
Regulatory Status
RX
Drug Name
SULINDAC
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1991-09-06
Active Ingredient
SULINDAC
Application Number
73262
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1991-09-06
Regulatory Status
Discontinued
Drug Name
SULINDAC
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1991-09-06
Active Ingredient
SULINDAC
Application Number
73262
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
1991-09-06
Regulatory Status
Discontinued
Drug Name
SULSTER
Product Number
1
Dosage Form
-
Strength
EQ 0.23% PHOSPHATE;10%
Approval Date
1996-07-30
Active Ingredient
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
Application Number
74511
Product Number
1
Dosage Form
-
Strength
EQ 0.23% PHOSPHATE;10%
Approval Date
1996-07-30
Regulatory Status
Discontinued
Drug Name
TAPENTADOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2026-01-27
Active Ingredient
TAPENTADOL HYDROCHLORIDE
Application Number
214378
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2026-01-27
Regulatory Status
RX
Drug Name
TAPENTADOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2026-01-27
Active Ingredient
TAPENTADOL HYDROCHLORIDE
Application Number
214378
Product Number
2
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2026-01-27
Regulatory Status
RX
Drug Name
TAPENTADOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2026-01-27
Active Ingredient
TAPENTADOL HYDROCHLORIDE
Application Number
214378
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2026-01-27
Regulatory Status
RX
Drug Name
TERBUTALINE SULFATE
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2008-01-07
Active Ingredient
TERBUTALINE SULFATE
Application Number
78151
Product Number
1
Dosage Form
-
Strength
1MG/ML
Approval Date
2008-01-07
Regulatory Status
Discontinued
Drug Name
THIAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1982-10-01
Active Ingredient
THIAMINE HYDROCHLORIDE
Application Number
87968
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1982-10-01
Regulatory Status
Discontinued
Drug Name
THIORIDAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
30MG/ML
Approval Date
1996-08-16
Active Ingredient
THIORIDAZINE HYDROCHLORIDE
Application Number
40125
Product Number
1
Dosage Form
-
Strength
30MG/ML
Approval Date
1996-08-16
Regulatory Status
Discontinued
Drug Name
THIORIDAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1996-08-16
Active Ingredient
THIORIDAZINE HYDROCHLORIDE
Application Number
40126
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
1996-08-16
Regulatory Status
Discontinued
Drug Name
THIOTHIXENE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1987-06-24
Active Ingredient
THIOTHIXENE
Application Number
71529
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1987-06-24
Regulatory Status
Discontinued
Drug Name
THIOTHIXENE
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1987-06-24
Active Ingredient
THIOTHIXENE
Application Number
71529
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1987-06-24
Regulatory Status
Discontinued
Drug Name
THIOTHIXENE
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1987-06-24
Active Ingredient
THIOTHIXENE
Application Number
71529
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1987-06-24
Regulatory Status
Discontinued
Drug Name
THIOTHIXENE
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
1987-06-24
Active Ingredient
THIOTHIXENE
Application Number
71529
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
1987-06-24
Regulatory Status
Discontinued
Drug Name
TIMOLOL
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2016-09-30
Active Ingredient
TIMOLOL
Application Number
205309
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
2016-09-30
Regulatory Status
Discontinued
Drug Name
TIMOLOL
Product Number
2
Dosage Form
-
Strength
0.5%
Approval Date
2016-09-30
Active Ingredient
TIMOLOL
Application Number
205309
Product Number
2
Dosage Form
-
Strength
0.5%
Approval Date
2016-09-30
Regulatory Status
Discontinued
Drug Name
TIMOLOL MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 0.25% BASE
Approval Date
1997-03-25
Active Ingredient
TIMOLOL MALEATE
Application Number
74465
Product Number
1
Dosage Form
-
Strength
EQ 0.25% BASE
Approval Date
1997-03-25
Regulatory Status
Discontinued
Drug Name
TIMOLOL MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 0.25% BASE
Approval Date
1997-03-25
Active Ingredient
TIMOLOL MALEATE
Application Number
74515
Product Number
1
Dosage Form
-
Strength
EQ 0.25% BASE
Approval Date
1997-03-25
Regulatory Status
Discontinued
Drug Name
TIMOLOL MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
1997-03-25
Active Ingredient
TIMOLOL MALEATE
Application Number
74516
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
1997-03-25
Regulatory Status
Discontinued
Drug Name
TIMOLOL MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
2020-09-11
Active Ingredient
TIMOLOL MALEATE
Application Number
212291
Product Number
1
Dosage Form
-
Strength
EQ 0.5% BASE
Approval Date
2020-09-11
Regulatory Status
RX
Drug Name
TIZANIDINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2002-10-11
Active Ingredient
TIZANIDINE HYDROCHLORIDE
Application Number
76347
Product Number
1
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2002-10-11
Regulatory Status
RX
Drug Name
TIZANIDINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2002-10-11
Active Ingredient
TIZANIDINE HYDROCHLORIDE
Application Number
76347
Product Number
2
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2002-10-11
Regulatory Status
RX
Drug Name
TOBRAMYCIN SULFATE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
2014-09-16
Active Ingredient
TOBRAMYCIN SULFATE
Application Number
205179
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE/ML
Approval Date
2014-09-16
Regulatory Status
Discontinued
Drug Name
TRANDOLAPRIL
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2007-06-12
Active Ingredient
TRANDOLAPRIL
Application Number
77256
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2007-06-12
Regulatory Status
Discontinued
Drug Name
TRANDOLAPRIL
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2007-06-12
Active Ingredient
TRANDOLAPRIL
Application Number
77256
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2007-06-12
Regulatory Status
Discontinued
Drug Name
TRANDOLAPRIL
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2007-06-12
Active Ingredient
TRANDOLAPRIL
Application Number
77256
Product Number
3
Dosage Form
-
Strength
4MG
Approval Date
2007-06-12
Regulatory Status
Discontinued
Drug Name
TRANDOLAPRIL
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2008-06-18
Active Ingredient
TRANDOLAPRIL
Application Number
78508
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2008-06-18
Regulatory Status
RX
Drug Name
TRANDOLAPRIL
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2008-06-18
Active Ingredient
TRANDOLAPRIL
Application Number
78508
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2008-06-18
Regulatory Status
RX
Drug Name
TRANDOLAPRIL
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
2008-06-18
Active Ingredient
TRANDOLAPRIL
Application Number
78508
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
2008-06-18
Regulatory Status
RX
Drug Name
TRANEXAMIC ACID
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2011-11-17
Active Ingredient
TRANEXAMIC ACID
Application Number
202373
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2011-11-17
Regulatory Status
RX
Drug Name
TRANEXAMIC ACID
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2017-09-28
Active Ingredient
TRANEXAMIC ACID
Application Number
206594
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2017-09-28
Regulatory Status
Discontinued
Drug Name
TRIAMCINOLONE ACETONIDE
Product Number
1
Dosage Form
-
Strength
0.025%
Approval Date
2013-05-08
Active Ingredient
TRIAMCINOLONE ACETONIDE
Application Number
202374
Product Number
1
Dosage Form
-
Strength
0.025%
Approval Date
2013-05-08
Regulatory Status
RX
Drug Name
TRIAMCINOLONE ACETONIDE
Product Number
2
Dosage Form
-
Strength
0.1%
Approval Date
2013-05-08
Active Ingredient
TRIAMCINOLONE ACETONIDE
Application Number
202374
Product Number
2
Dosage Form
-
Strength
0.1%
Approval Date
2013-05-08
Regulatory Status
RX
Drug Name
TRIAMCINOLONE DIACETATE
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Active Ingredient
TRIAMCINOLONE DIACETATE
Application Number
85122
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
TRIAMCINOLONE DIACETATE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
1982-01-01
Active Ingredient
TRIAMCINOLONE DIACETATE
Application Number
86394
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
Product Number
1
Dosage Form
-
Strength
10,000 UNITS/ML;EQ 1MG BASE/ML
Approval Date
1998-12-17
Active Ingredient
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
Application Number
65006
Product Number
1
Dosage Form
-
Strength
10,000 UNITS/ML;EQ 1MG BASE/ML
Approval Date
1998-12-17
Regulatory Status
RX
Drug Name
TROPICACYL
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
2000-09-29
Active Ingredient
TROPICAMIDE
Application Number
40314
Product Number
1
Dosage Form
-
Strength
0.5%
Approval Date
2000-09-29
Regulatory Status
RX
Drug Name
TROPICAMIDE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1985-08-28
Active Ingredient
TROPICAMIDE
Application Number
88447
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
1985-08-28
Regulatory Status
Discontinued
Drug Name
URSODIOL
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2000-03-14
Active Ingredient
URSODIOL
Application Number
75517
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
2000-03-14
Regulatory Status
RX
Drug Name
URSODIOL
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2024-08-14
Active Ingredient
URSODIOL
Application Number
214717
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2024-08-14
Regulatory Status
RX
Drug Name
URSODIOL
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2024-08-14
Active Ingredient
URSODIOL
Application Number
214717
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2024-08-14
Regulatory Status
RX
Drug Name
VORICONAZOLE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2016-09-07
Active Ingredient
VORICONAZOLE
Application Number
207049
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2016-09-07
Regulatory Status
RX
Drug Name
VORICONAZOLE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2016-09-07
Active Ingredient
VORICONAZOLE
Application Number
207049
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2016-09-07
Regulatory Status
RX
Drug Name
XYLOCAINE
Product Number
1
Dosage Form
-
Strength
2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
8816
Product Number
1
Dosage Form
-
Strength
2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
ZOLEDRONIC ACID
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/100ML
Approval Date
2014-08-21
Active Ingredient
ZOLEDRONIC ACID
Application Number
200918
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/100ML
Approval Date
2014-08-21
Regulatory Status
RX
Drug Name
ZOLEDRONIC ACID
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/5ML
Approval Date
2014-05-22
Active Ingredient
ZOLEDRONIC ACID
Application Number
202548
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE/5ML
Approval Date
2014-05-22
Regulatory Status
RX
Drug Name
ZONISAMIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2007-02-21
Active Ingredient
ZONISAMIDE
Application Number
77876
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2007-02-21
Regulatory Status
Discontinued
Drug Name
ZONISAMIDE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2007-02-21
Active Ingredient
ZONISAMIDE
Application Number
77876
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2007-02-21
Regulatory Status
Discontinued
Drug Name
ZONISAMIDE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2007-02-21
Active Ingredient
ZONISAMIDE
Application Number
77876
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2007-02-21
Regulatory Status
Discontinued
Drug Status Breakdown
360 total- RX
- Discontinued
- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ACETAZOLAMIDE
Application Number
218023
Product Number
1
Active Ingredient
ACETAZOLAMIDE
Dosage Form
-
Strength
125MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.